LLC Insight Holdings Group Buys Hinge Health Shares
LLC Insight Holdings Group increased its stake in Hinge Health, Inc. with a recent purchase.
Key Points
- LLC Insight Holdings Group bought 530,982 shares of Hinge Health, Inc. recently.
- Hinge Health shares were trading at $78.97 on Tuesday with a market cap of $6.11 billion.
- Analysts like Wells Fargo and Raymond James maintain a 'buy' rating with targets up to $90.00.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
LLC Insight Holdings Group recently made a significant move by purchasing 530,982 shares of Hinge Health, Inc. (NYSE: HNGE). This transaction was recorded on June 25, 2026. Shares of Hinge Health traded at $78.97 on Tuesday.
What Changed in LLC Insight Holdings Group's Hinge Health Position
This purchase by LLC Insight Holdings Group adds to its existing position in Hinge Health, Inc. It's part of ongoing activity by the group in the company's stock, reflecting their interest in Hinge Health's market opportunities.
Other Institutional Activity in Hinge Health
Other institutional investors have also been active in Hinge Health. Deer Management Co. LLC opened a new position with 2,633,707 shares valued at about $101.6 million. Bit Capital GMBH reduced its holdings by 1,006,304 shares, ending with 2,309,797 shares worth approximately $89.1 million, marking a 30.3% decrease. RTW Investments, LP significantly increased its stake by 1,576,500 shares, now holding 1,930,000 shares valued at roughly $74.4 million, a 446% increase.
Hinge Health, Inc. Stock Down 6.7%
Shares of Hinge Health, Inc. (NYSE: HNGE) traded near $78.97 on Tuesday. The company has a market capitalization of approximately $6.11 billion. Its forward P/E ratio is 23.46, and the stock has a 52-week range between $30.08 and $79.26. The 50-day moving average is $56.38, while the 200-day moving average is $48.25. Hinge Health maintains a current ratio of 1.30 and a quick ratio of 1.04, with a debt-to-equity ratio of 2.24.
$HNGE stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Hinge Health reported revenue of $646.3 million with a revenue growth rate of 47.2%. However, the company is not currently profitable, as indicated by its negative net margin of -78.95% and return on equity of -136.00%. The next earnings report is expected on August 4, 2026.
Insider Buying and Selling at Hinge Health, Inc.
LLC Insight Holdings Group has been active with multiple transactions. On June 25, 2026, they purchased 530,982 shares. Additionally, on June 29, 2026, they executed both planned and unplanned transactions, buying and selling 1,466,667 shares respectively.
Analysts Set New Price Targets
Analysts are optimistic about Hinge Health. On June 24, 2026, Wells Fargo maintained a 'buy' rating with a price target of $90.00. Raymond James also kept a 'buy' rating with a target of $80.00 on June 15, 2026. Overall, the consensus recommendation is a 'buy', with a mean target price of $82.07 among 15 analysts.
About Hinge Health, Inc.
Hinge Health, Inc. is a healthcare company based in San Francisco, California, led by CEO Daniel A. Perez. The company focuses on musculoskeletal (MSK) care, providing solutions for acute injuries, chronic pain, and post-surgical rehabilitation through a technology-driven platform. Their services primarily cater to self-insured employers, utilizing AI-powered motion tracking and a proprietary wearable device.
Bottom Line
Hinge Health, Inc. has attracted attention from LLC Insight Holdings Group, which recently increased its stake in the company. Despite current unprofitability, the company shows promise with substantial revenue growth and a focus on innovative healthcare solutions. Investors and analysts continue to watch Hinge Health closely, although it's important to remember that insider transactions are reported after the fact and may not indicate future performance.
Get Hinge Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.